AUG 20, 2026 · PHASE 2 TRIAL
Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov
Phase 2 trial with estimated enrollment of 36 participants testing a four-drug combination; no results are reported in this registry record.
Reported
PhasePhase 2
Planned enrollment36
Primary outcome measureObjective Response at 6 months (initiation…